Home Tags Medical Research
Tag: Medical Research News
Drink HRW Reports on Start of Large-Scale Randomized Controlled Trial and Preliminary Findings from Pilot Trial on the Reduction in Complications...
COQUITLAM, BC, Canada, Jan. 19, 2021 (SEND2PRESS NEWSWIRE) -- Drink HRW is excited to announce that a large, double-blind placebo-controlled trial is set to begin this week in France, initiated by the University of Grenoble-Alpes. At the request of the researchers, Drink HRW is supplying the hydrogen tablets for the study as well as a donation to improve the size and scope of the research. It has no other involvement in the research or the decision to publish results.
TAMPA, Fla., Jan. 13, 2021 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation will host a free, live-online, and interactive symposium on Friday, Jan. 15 from 1 to 4 p.m. EST. Sponsored by Seres Therapeutics, the event is designed for patients who are being treated for a C. diff. infection in addition to those who are recovering or who have experienced recurrences. The patients, family members and caregivers will all benefit from the information and up-to-date data presented.
TAMPA, Fla., Jan. 11, 2021 (SEND2PRESS NEWSWIRE) -- While some patients diagnosed with Clostridioides difficile (C. diff., C. difficile, CDI) believe they have run into clinical trial roadblocks, due to the recent focus on the pandemic, the C Diff Foundation wants them to know they are not out of options. Safe and active clinical trials continue.
Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID 19 Vaccine Under Fast Track CARES Act...
AUSTIN, Texas, Nov. 17, 2020 (SEND2PRESS NEWSWIRE) -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2 Delivery Platform.
2020 International Clostridioides difficile (C. diff., C. difficile) Virtual Conference and Health EXPO Nov. 14
TAMPA, Fla., Nov. 11, 2020 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that the 8th Annual International C. diff. Virtual-Online Conference and Health EXPO will be a 5-1/2 hour online program with over fourteen international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies.
VENTURA, Calif. /California Newswire/ -- The American College of Gastroenterology (ACG) named Progenabiome "Outstanding Poster Presenter" for its poster: "Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for Clostridioides difficile Infection," which will be presented virtually at the ACG Annual Scientific Meeting this week.
ProgenaBiome Announces Alzheimer’s Patient Recalls Daughter’s Birthday After Undergoing Fecal Transplant
VENTURA, Calif. /California Newswire/ -- Dr. Sabine Hazan, founder of ProgenaBiome, a genetic sequencing lab in California, achieved rapid improvement in Alzheimer's disease (AD) symptoms in an 82-year-old male patient following fecal microbiota transplantation (FMT).
NED Biosystems Announces Leading Infectious Disease Research Scientist Michael Mansour, MD, PhD To Serve as Medical Advisor
CAMBRIDGE, Mass., Oct. 6, 2020 (SEND2PRESS NEWSWIRE) -- NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour, MD, PhD, will serve as the Company's Medical Advisor of Infectious Disease.
Leading Experts in Cancer Research Nabeel El-Bardeesy and Razelle Kurzrock Join NED Biosystems’ Scientific Advisory Board
CAMBRIDGE, Mass., Sept. 2, 2020 (SEND2PRESS NEWSWIRE) -- NED Biosystems, an innovative clinical-stage biotech company developing oral therapies for cancer and novel coronavirus, is pleased to announce that Nabeel El-Bardeesy, PhD and Razelle Kurzrock, MD have joined the Company's Scientific Advisory Board.
STONY BROOK, N.Y., July 20, 2020 (SEND2PRESSN NEWSWIRE) -- Zeblok Computational is contributing to the efforts of two groups of researchers at The Laufer Center for Physical and Quantitative Biology, for COVID-19 drug discovery by providing Zeblok's secure, scalable Supercomputing-as-a-Service platform, employing 128 GPUs from the CEWIT SMART GPU Cluster.
ROKiT Pharma Pre-clinical Studies Show Tremendous Promise for Naturally Derived Cancer Drug, ROK-001
LOS ANGELES, Calif. /California Newswire/ -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients.
YAP, Micronesia, March 18, 2020 (SEND2PRESS NEWSWIRE) -- Schizophrenia may find a cure in individualized treatment. So says a new article in the science journal Holistic Nursing Practice. According to Dr. Daniel Helman, a researcher on the small island of Yap in Micronesia, long-term recovery is often possible, but appropriate studies are not being done.
DALLAS, Texas, March 10, 2020 (SEND2PRESS NEWSWIRE) -- Susan G. Komen Dallas County (Komen Dallas County) today said it has received bequests from the Estate of Edith Beutell and the Estate of Dr. Glenn Dodwell, which combined total more than $199,000. The gifts will further the organization's ability to assess the state of breast health in Dallas County and create plans of action to reduce breast cancer mortality disparities in the community.
SAN DIEGO, Calif. /California Newswire/ -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the opening of the San Diego collection site of the Bay Area Lyme Foundation's Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from people with early Lyme disease from multiple endemic regions across the country.
ROSELAND, N.J., Feb. 27, 2020 (SEND2PRESS NEWSWIRE) -- The Sudden Unexplained Death in Childhood (SUDC) Foundation thanks Alabama, Arkansas, Florida, Georgia, Hawaii, Illinois, Iowa, Louisiana, Massachusetts, Mississippi, New Hampshire, New York, North Carolina, North Dakota, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, West Virginia for making statewide proclamations declaring March 2020 SUDC Awareness Month.
Susan G. Komen North Jersey Announces Award Honorees Robert C. Garrett, Amparo Aguirre and LAX for the Cure
PARSIPPANY, N.J., Feb. 18, 2020 (SEND2PRESS NEWSWIRE) -- Susan G. Komen® North Jersey today announced its Pink Tie Party honorees to be recognized during the March 21st event being held at Ruth's Chris Steak House in Jersey City. For over twenty years, Susan G. Komen North Jersey has helped those who can't pay for treatments, worked to ensure that all people get the care they need, fought for the rights of patients with policy makers and funded breakthroughs in research that saves lives.
Introducing The CALNOC Nightingale Research Fund: Raising Nursing’s Voice in Health Services Research
WALNUT CREEK, Calif. /California Newswire/ -- CALNOC is pleased to introduce The CALNOC Nightingale Research Fund, an innovative and opportune resource in health services research focused on and administrated by nursing. We are excited to announce the Research Fund today in honor of Florence Nightingale and in celebration of the Year of the Nurse 2020.
CINCINNATI, Ohio, Nov. 22, 2019 (SEND2PRESS NEWSWIRE) -- The OLFACT Test Battery, developed by Osmic Enterprises, was initially developed to detect olfactory impairments. Now, it's been adapted as an automated, self-administered screening test to predict Alzheimer's disease/dementia and is being tested by a number of prominent physicians and research laboratories around the United States and in China.
SAN DIEGO, Calif. /California Newswire/ -- SciScore announces the release of its innovative solution, the first and only working application of its kind, in support of the pre-clinical scientific research community's pursuit of reproducibility and transparency.
iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations at 61st American Society of Hematology Annual Meeting
STONY BROOK, N.Y., Nov. 14, 2019 (SEND@PRESS NEWSWIRE) -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to be held December 7-10, 2019 in Orlando, Florida.
NEW PORT RICHEY, Fla., Nov. 14, 2019 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation reemphasizes that the month of November is "C. diff. awareness month" and is being recognized with its partners around the globe again in 2019.
AUSTIN, Texas, Nov. 1, 2019 (SEND2PRESS NEWSWIRE) -- The National Deaf Chamber of Commerce (NDCOC), the first organization truly dedicated to advocating and protecting the interests of the Deaf business community, is pleased to announce its Board of Directors, Gina D'Amore, Michael Pimentel, Evan Winegard, and Jared Allebest.
NEW YORK, N.Y., Oct. 16, 2019 (SEND2PRESS NEWSWIRE) -- The Lupus Research Alliance (LRA) is pleased to announce that seasoned professional Penny Mitchell has joined the organization as Senior Director of Marketing and Communications. In her new role, Ms. Mitchell will oversee the organization's strategic communications approach to leading lupus research worldwide and the value of participation by all sectors of the lupus community.
C Diff Foundation’s Junior Infection Fighters Program Takes Action against Harmful Germs One Community at a Time Worldwide
NEW PORT RICHEY, Fla., Oct. 16, 2019 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that the inaugural C Diff Foundation Junior Infection Fighter Program was introduced to families and their children/teens in Chester County, Pennsylvania on October 12, 2019.
C Diff Foundation Raises Clostridioides difficile Awareness in St. Louis on Nov. 6-7 at 7th Annual International Conference and Health EXPO
ST. LOUIS, Mo., Oct. 14, 2019 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that the 7th Annual International C. diff. Conference and Health EXPO is honored to welcome over 30 international topic-experts dedicated in disciplines of healthcare, pharma, biotech, academia, and Government agencies. November 6 - 7, 2019 at the DoubleTree by Hilton Westport Hotel.
Neurotech Leaders Forum 2019 in San Francisco: Fifteen Neurotechnology Startups to Present at the Event
SAN FRANCISCO, Calif. /California Newswire/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5. The 19th annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.
NEW YORK, N.Y., Oct. 4, 2019 (SEND2PRESS NEWSWIRE) -- Join New York's lupus community and the Lupus Research Alliance (LRA) Saturday, October 12 to Walk with Us to Cure Lupus at the Intrepid Sea, Air & Space Museum in Manhattan.
Susan G. Komen North Jersey’s MORE THAN PINK Wellness Expo, Presented by Aetna, Comes to Jersey City, NJ Sunday, October 6
JERSEY CITY, N.J., Oct. 1, 2019 (SEND2PRESS NEWSWIRE) -- Susan G. Komen North Jersey, will be holding its MORE THAN PINK Wellness Expo on Sunday, October 6, 2019 at the Harborside Atrium in Jersey City from 12 p.m. - 4 p.m. This interactive health and wellness expo will offer attendees convenient access to education and critical health screening services, health/wellness exhibits, fitness/nutrition demonstrations, survivor support, a senior pavilion, medical information and genetic testing.
WEEHAWKEN, N.J., Oct. 1, 2019 (SEND2PRESS NEWSWIRE) -- Susan G. Komen North Jersey announced today it presented its inaugural Community Impact Award to Arthur Imperatore Sr., Founder and resident of NY Waterway, the largest commuter ferry fleet in New York Harbor, providing commuter ferry and bus services between New Jersey and Manhattan.
SYOSSET, N.Y., Sept., 20, 2019 (SEND2PRESS NEWSWIRE) -- Fluid Metering, Inc., a pioneer in design and manufacturing of high-performance fluid handling solutions, is pleased to announce a new distribution agreement with REVODIX Inc. This partnership leverages the combined strength of Fluid Metering's ultra-precise fluid control products with REVODIX's dedicated focus and distribution expertise.
C.diff. International Conference and Health EXPO Will Deliver Up-to-date Clostridioides difficile Data + More Nov. 6-7 In St. Louis
ST. LOUIS, Mo., July 11, 2019 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation is honored to welcome 30+ international leading topic experts from hospitals, pharma, biotech, academia, and Government agencies to deliver and discuss critical information on global healthcare-associated issues.
Founder of Stillbrave Childhood Cancer Foundation to Run 206-Mile Ultra-Marathon on Mount St. Helens Volcano
BURKE, Va., July 1, 2019 (SEND2PRESS NEWSWIRE) -- Stillbrave Childhood Cancer Foundation announced that its founder and director, "Tattoo Tom" Mitchell is on a mission to raise $500,000 to support children with cancer and their families. From August 9 through 13, he will return to Mount St. Helens to make his fourth attempt at what's been called "the most challenging endurance race in North America" - the Bigfoot 200.
2019 Lupus Insight Prize Awarded to Dr. Ignacio Sanz: Recognizes Studies of Harmful Immune Cells in Lupus
BOSTON, Mass., June 19, 2019 (SEND2PRESS NEWSWIRE) -- The Lupus Research Alliance has awarded its 2019 Lupus Insight Prize to Ignacio Sanz, MD, for discovering that certain little-understood immune system cells are a major source of the harmful proteins that promote lupus symptoms. His work could spark new treatments for the disease and help doctors determine which patients could benefit from current drugs.
World Renowned C Diff Foundation Announces First Ever Appointment of Paul Feuerstadt, M.D. as Director of Medical Education
NEW PORT RICHEY, Fla., May 22, 2019 (SEND2PRESS NEWSWIRE) -- C Diff Foundation, a one hundred percent volunteer, world renowned 501(c)(3) not-for-profit organization, has appointed nationally renowned Gastroenterologist, Dr. Paul Feuerstadt as its first Director of Medical Education.
New Research Sheds Light on Potential Role of Febrile Seizures and Other Risk Factors in Sudden Deaths in Children
ROSELAND, N.J., April 26, 2019 (SEND2PRESS NEWSWIRE) -- The SUDC Foundation highlights newly-published research from the Journal of American Medical Association (JAMA) that identifies an increased rate of febrile seizures among children who die suddenly, both with and without explanation. The authors of the article report the need for more research.
TEANECK, N.J., April 16, 2019 (SEND2PRESS NEWSWIRE) -- C Diff Foundation announced today that registration is now open for the 3rd Annual Global C.diff. Awareness 2K Walks. The events, which will take place at the Morris A. Votee Park, Teaneck, N.J., Charlestown Township Park, Phoenixville, Pa., and Sims Park, New Port Richey, Fla., will be hosted by the C Diff Foundation on Saturday, May 18, 2019 from 8 a.m. - 12 p.m.
The C Diff Foundation Has Declared an Urgent Need to Raise Clostridium difficile Infection Clinical Trial Awareness Worldwide
TAMPA, Fla., Feb. 21, 2019 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation announced today that their organization has implemented a global campaign to raise awareness of Clostridioides difficile clinical trials, clinical studies, clinical research and observational studies evaluating interventions for C. difficile prevention, treatments, and environmental safety.
PHILADELPHIA, Pa., June 11, 2018 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation is honored to welcome 20+ leading topic experts joined by Dale Gerding, MD, FACP, FIDSA, Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois and Research Physician at the Edward Hines Jr. VA Hospital and Mark Wilcox, B Med Sci, BM, BS, MD, FRCPath-, Head of Microbiology and Academic Lead of Pathology at the Leeds Teaching Hospitals (LTHT).
2nd Annual Global C.diff. Walks in NJ and FL to Raise Awareness on Importance of Clostridium difficile Infections Worldwide
TEANECK, N.J., May 15, 2018 (SEND2PRESS NEWSWIRE) -- Presented by the C Diff Foundation, the 2nd Annual Global C.diff. Awareness 2K Walks will take place on Saturday, May 19 at three separate locations: Morris A. Votee Park, Teaneck, New Jersey; Sims Park, New Port Richey, Florida; and in Leicester, England. All locations will include t-shirts and resourceful educational material for all registered walkers. The U.S. locations will also include water bottles and hydration stations.
NEW PORT RICHEY, Fla., March 16, 2018 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation announced today that it presented CutisPharma, Inc., its "Making a Difference" award as a special recognition of the significant contribution that CutisPharma has made to the C.diff. Community: helping the advancement of C.diff. awareness as well as expanding treatment options for C.diff. patients.
Neurotech Reports Announces 2018 Investment and Management Conference for Bioelectronic Medicine in NYC
NEW YORK, N.Y., Jan. 30, 2018 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of Neurotech Business Report newsletter, today announced the launch of the Bioelectronic Medicine Forum, the first investment and management conference for the bioelectronic medicine industry. The inaugural event will take place on March 22, 2018 at the Millennium Broadway Times Square in New York, N.Y.
KESWICK, Va., Jan. 23, 2018 (SEND2PRESS NEWSWIRE) -- Did you know that every person has 50,000 miles of blood vessels that are exposed to deadly iron? This is the concept that will be addressed by William J. Rowe, M.D. at the upcoming Internal Medicine and Patient Care Conference, March 26-27, 2018 in Vienna, Austria.
The C Diff Foundation Raises Clostridium difficile Infection Clinical Trial Awareness in 2018 Worldwide
TAMPA, Fla., Jan. 22, 2018 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation announced today that their organization has implemented a global campaign to raise awareness of Clostridium difficile infection (C.difficile) clinical trials, clinical studies, clinical research and observational studies evaluating interventions for C. difficile prevention, treatments, and environmental safety.
C DIFF NEWS: U.S. Governors Applauded for Proclaiming November 2017 Clostridium difficile Infection Awareness Month
BALTIMORE, Md., Nov. 27, 2017 (SEND2PRESS NEWSWIRE) -- Many U.S. Governors have signed a state proclamation proclaiming November 2017 as Clostridium difficile (C.difficile, C.diff.) Infection Awareness Month, the non-profit C Diff Foundation announced today.
In Florida, Inaugural Global C. diff. Walk to raise awareness on importance of Clostridium difficile infection prevention
NEW PORT RICHEY, Fla., Oct. 3, 2017 (SEND2PRESS NEWSWIRE) -- Presented by the C Diff Foundation, the 1st Annual Global C.diff. Awareness 2K Walk will take place on Saturday, November 4 at Frances Park, New Port Richey, Florida. This event will include refreshments, hydration stations, and resourceful educational material and displays.
C Diff Foundation Knocks on Governor’s Doors Nationwide Proclaiming November for Clostridium difficile Infection Awareness
NEW PORT RICHEY, Fla., Sept. 28, 2017 (SEND2PRESS NEWSWIRE) -- C Diff Foundation welcomes November as Clostridium difficile Awareness Month and it is an exciting time for patients, families, clinicians, and organizations. Governors in several states honor our efforts by signing proclamations declaring November to be Clostridium difficile Awareness Month in their states.
Critical Healthcare-acquired Infections Solutions Expo comes to Las Vegas, Addressing C.difficile Concerns and Patient Risks
LAS VEGAS, Nev., Aug. 16, 2017 (SEND2PRESS NEWSWIRE) -- C Diff Foundation welcomes Dale Gerding, MD, FACP, FIDSA, and Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois and Research Physician at the Edward Hines Jr. VA Hospital as Conference Chair of the upcoming 5th Annual International "C.diff. Awareness Conference and Health EXPO," taking place on November 9 and 10, 2017 at the University of Nevada - Las Vegas, Thomas and Mack Center, 2nd Floor Pavilion.
ATLANTA, Ga., July 20, 2017 (SEND2PRESS NEWSWIRE) -- C Diff Foundation's "C. diff. Spores and More Global Broadcasting Network" is honored to announce Doctors McDonald and Laufer-Halpin as our guest speakers on July 25, 2017 at 10 a.m. PT / 1 p.m. ET on C Diff Radio.
TAMPA, Fla., July 11, 2017 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation is pleased to announce the Michael and Helen Caralla, Sr. Educational Scholarship program. The scholarship program is to help health care students succeed and reach their educational goals.
NEW YORK, N.Y., June 6, 2017 (SEND2PRESS NEWSWIRE) -- The Myasthenia Gravis Foundation of America (MGFA), the nonprofit dedicated to raising research funds for and awareness of the neuromuscular disease myasthenia gravis (MG), announces that Chef Sean Brock has graciously volunteered to be an Awareness Ambassador for the organization.
12Page 1 of 2